Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis

Mycobacterium tuberculosis remains a leading cause of infectious disease morbidity and mortality for which new drug combination therapies are needed. Mycobacterial bioenergetics has emerged as a promising space for the development of novel therapeutics. Further to this, unique combinations of respir...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeil, Matthew B., Cheung, Chen-Yi, Waller, Natalie J. E., Adolph, Cara, Chapman, Cassandra L., Seeto, Noon E. J., Jowsey, William, Li, Zhengqiu, Hameed, H. M. Adnan, Zhang, Tianyu, Cook, Gregory M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461714/
https://www.ncbi.nlm.nih.gov/pubmed/36093195
http://dx.doi.org/10.3389/fcimb.2022.980844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461714/
https://www.ncbi.nlm.nih.gov/pubmed/36093195
http://dx.doi.org/10.3389/fcimb.2022.980844

Ejemplares similares